New Delhi: Serum Institute of India, thecountry`s largest vaccine maker, today announced the launch ofits indigenously developed intra-nasal vaccine, Nasovac, forpreventing H1N1 infections. The single dose vaccine, fitted at the top of a syringe,is just to be sniffed once in each nostril, making it apainless prevention mode, the company said in a statement.
With the outbreak of H1N1 infections in 2009, the SerumInstitute, in consultation with the World Health Organisation(WHO) and the Ministry of Health, had started work on the H1N1vaccine. The company is also working on an influenza vaccine underWHO guidance. Serum Institute of India is the world`s largest DTP(Triple) and measles vaccine manufacturer. The company`sproducts are exported to over 130 countries worldwide. -PTI
Excess computer work creates craving for sweets
India aims to grow sea buckthorn in 1 mn hectare by 2020